Artigo
Acesso aberto
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2019; Elsevier BV; Linguagem: Inglês
10.1002/14651858.cd004290.pub3
ISSN1465-1858
AutoresDeirdré Hahn, Elisabeth M Hodson, Lorraine Hamiwka, Vincent Lee, Jeremy R. Chapman, Jonathan C. Craig, Angela C Webster,
Tópico(s)Adenosine and Purinergic Signaling
ResumoTarget of rapamycin inhibitors (
Referência(s)